nasacort 55 mikrog/ dose
opella healthcare france sas - triamcinolonacetonid - nesespray, suspensjon - 55 mikrog/ dose
pevisone 1 mg/ g / 10 mg/ g
karo pharma ab (1) - triamcinolonacetonid / ekonazolnitrat - krem - 1 mg/ g / 10 mg/ g
synalar 0.025 %
bioglan ab - fluocinolonacetonid - gel - 0.025 %
livicort 64 mikrog/ dose
mcneil sweden ab - budesonid - nesespray, suspensjon - 64 mikrog/ dose
livicort 32 mikrog/ dose
mcneil sweden ab - budesonid - nesespray, suspensjon - 32 mikrog/ dose
weifapenin 50 mg/ ml
viatris as - fenoksymetylpenicillinkalium - pulver til mikstur, oppløsning - 50 mg/ ml
basiron ac 5 %
galderma nordic ab - benzoylperoksid, vandig - gel - 5 %
basiron ac 10 %
galderma nordic ab - benzoylperoksid, vandig - gel - 10 %
flunixin biovet vet 50 mg/ ml
biovet aps - fluniksinmeglumin - injeksjonsvæske, oppløsning - 50 mg/ ml
idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunsuppressive - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.